Pear Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:PEAR   1:30:24 PM EDT
4.13
+0.01 (+0.24%)
Earnings Announcements

Pear Therapeutics Says Total Revenue For Q4 Of 2021 Was $1.3 Million

Published: 03/28/2022 20:15 GMT
Pear Therapeutics Inc - Ordinary Shares - Class A (PEAR) - Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results.
Pear Therapeutics Inc - Pear's Total Revenue for Q4 of 2021 Was $1.3 Million, Compared With $34 Thousand.
Pear Therapeutics Inc - Qtrly Earnings per Share $0.13.
Revenue is expected to be $4.28 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $6.26 Million
Next Quarter EPS Guidance is expected to be -$0.24

More details on our Analysts Page.